The essential metal (Cu, Zn, Fe, Ca, Mg, Na and K) tissue content in Lewis-lung-carcinoma-bearing mice was compared with that of pregnant mice as well as with controls and with mice both pregnant and cancerous. All comparisons were done on day 17 after inoculation/Impregnation on C57BL/6 age-matched female mice. Despite unchecked tumour growth and metastasizing ability, pregnancy effectively prevented the tissue-wasting effect of the tumour. The economy of all the essential metals studied followed practically the same pattern. The combined tumour-bearing and pregnancy situation was much closer to that of pregnancy than to the tumour-bearing alone, either at individual tissue concentration level or at that of the whole animal, in the maternal tissue and metal stores and tissue concentrations in front of the cachexic effect of tumour-bearing. Neither fetal nor tumour growth nor their metal content were impaired by the presence of the tumour/concepta. The maternal processes that allow for a higher fetal uptake of substrates seem to increase at least in the case of iron – the ability of the tumour to accumulate some metals.

Keywords:
Lewis lung carcinoma, Pregnancy, Essential metals
This content is only available via PDF.
© 1987 S. Karger AG, Basel
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.